⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Shareholder Notice: Robbins LLP Informs Investors of the ARS Pharmaceuticals Inc. Class Action
businesswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of ARS Pharmaceuticals, Inc. Securities and Sets a Lead Plaintiff Deadline of October 5, 2026
globenewswire.com
SPRY
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
globenewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
prnewswire.com
SPRY
Spryte Medical Completes INSYTE Trial Enrollment
globenewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
accessnewswire.com
SPRY